Several types of cells can be used in allogeneic therapies for cancer:
1. T-cells: Engineered T-cells, such as CAR-T cells, are designed to target specific cancer antigens. 2. Natural Killer (NK) Cells: These cells have innate ability to kill cancer cells without prior sensitization. 3. Dendritic Cells: These cells can be used to present antigens to the immune system, thereby stimulating a robust immune response against cancer. 4. Stem Cells: Hematopoietic stem cells from donors can be used to reconstitute a patient’s bone marrow after high-dose chemotherapy.
